Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Pharming Group NV

PHGN
0,7005
-0,018 (-2,51%)
19:53:34 - Dati in Tempo Reale
Borsa: Tradegate
Tipo: Azione Ordinaria
Valuta: EUR

Ultime notizie

Data Ora Fonte Titolo
24/10/202407:00UKREGPharming Group reports third quarter 2024 financial results..
10/10/202408:00UKREGPharming Group to report third quarter 2024 financial..
10/10/202407:00UKREGPharming Group announces start of Phase II clinical trial of..
26/9/202407:00UKREGPharming announces marketing authorization in the U.K. for..
01/8/202407:00UKREGPharming Group reports second quarter and first half 2024..
18/7/202408:00UKREGPharming Group to report second quarter and first half 2024..
03/6/202408:00GLOBEPharming Group to participate in June investor conferences
30/5/202422:44GLOBEPharming Group provides update on ongoing regulatory review..
21/5/202417:30GLOBEPharming Group reports on results of the 2024 Annual General..
20/5/202408:00GLOBEPharming Group to participate in May investor conference
15/5/202407:00GLOBEPharming Group announces the early redemption of the..
08/5/202407:00GLOBEPharming Group reports first quarter 2024 financial results..
24/4/202408:00GLOBEPharming Group to report first quarter 2024 financial..
24/4/202407:00GLOBEPharming to be honored as Industry Innovator at National ..
19/4/202418:43GLOBEPharming Group announces the repurchase of outstanding €125..
18/4/202415:04GLOBEPharming Group announces the placement of €100 million..
18/4/202408:00GLOBEPharming Group announces the launch of an offering of..
08/4/202407:00GLOBEPharming announces completion of enrollment in pediatric..
04/4/202408:30GLOBEPharming Group announces the 2024 Annual General Meeting of..
04/4/202407:00GLOBEPharming Group announces the filing of its 2023 Annual..
03/4/202408:00GLOBEPharming Group to participate in April investor conferences
14/3/202407:00GLOBEPharming Group reports fourth quarter and full year 2023..
29/2/202408:00GLOBEPharming Group to report fourth quarter and full year 2023..
08/2/202408:00GLOBEPharming Group to participate in February investor..
08/1/202407:00GLOBEPharming Group announces updated full year 2023 guidance and..
13/12/202307:00GLOBEPharming Group announces development plans for leniolisib..
Apertura: 0,7225 Min: 0,6895 Max: 0,7305
Chiusura: 0,7185

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network